Roche receives FDA clearance for new, highly-sensitive test to aid clinicians in diagnosing B-cell lymphomaThe VENTANA Kappa and Lambda Dual ISH assay is the first clinically approved test to identify B-cell lymphoma subtypes with high sensitivity.